Antibody Imaging in the Evaluation of Cardiovascular Diseases

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 1994 Sep 1

PMID 9420730

Citations 3

Authors

B A Khaw

J Narula

Affiliations

Soon will be listed here.

Abstract

Antimyosin antibody was originally developed for in vivo detection of acute myocardial infarction. However, its utility has expanded to include diagnosis of various cardiovascular diseases in which myocyte necrosis constitutes an obligatory component of the disease. Thus antimyosin has also been used clinically for noninvasive diagnosis of acute myocarditis, heart transplant rejection, drug-induced cardiotoxicity, and other cardiomyopathies. This first-generation monoclonal antibody, antimyosin, has opened the way for the second-generation monoclonal antibodies such as antifibrin and antiplatelet for in vivo diagnostic use in the detection of deep venous thrombosis and pulmonary embolism and antiatherosclerotic lesion-specific antibody for diagnosis of metabolically active lesions. Whether the third generation of antibodies will include ultrasmall antigen-binding units or negative charge-modified antibodies must await future studies.

Citing Articles

Breath Biomarkers in Diagnostic Applications.

Pham Y, Beauchamp J Molecules. 2021; 26(18).

PMID: 34576985 PMC: 8468811. DOI: 10.3390/molecules26185514.

Scleroderma heart disease: an unusual cause of positive antimyosin cardiac imaging.

Lekakis J, Mavrikakis M, Prassopoulos V, Gerali S, Sifakis N, KOSTAMIS P J Nucl Cardiol. 1999; 6(1 Pt 1):91-2.

PMID: 10070845 DOI: 10.1016/s1071-3581(99)90069-7.

Clinical future of antimyosin imaging in noncoronary heart disease.

Carrio I, Ballester M J Nucl Cardiol. 1995; 2(2 Pt 1):155-8.

PMID: 9420781 DOI: 10.1016/s1071-3581(95)80027-1.

References

Cuatrecasas P . Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem. 1970; 245(12):3059-65. View

Dec G, Palacios I, Yasuda T, Fallon J, Khaw B, Strauss H . Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol. 1990; 16(1):97-104. DOI: 10.1016/0735-1097(90)90463-y. View

Obrador D, Ballester M, Carrio I, Berna L, Pons-Llado G . High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1989; 13(6):1289-93. DOI: 10.1016/0735-1097(89)90303-3. View

Carrio I, Berna L, Ballester M, Estorch M, Obrador D, Cladellas M . Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med. 1988; 29(12):1893-900. View

Wasser M, Koppert P, Arndt J, Emeis J, Feitsma R, Pauwels E . An antifibrin monoclonal antibody useful in immunoscintigraphic detection of thrombi. Blood. 1989; 74(2):708-14. View

Minar E, Ehringer H, Dudczak R, Schofl R, Jung M, Koppensteiner R . Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke. 1989; 20(1):27-33. DOI: 10.1161/01.str.20.1.27. View

Volpini M, Giubbini R, Gei P, CUCCIA C, Franzoni P, Riva S . Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization. Am J Cardiol. 1989; 63(1):7-13. DOI: 10.1016/0002-9149(89)91066-7. View

Krause T, Schumichen C, Beck A, Lang B, Hohnloser S, Moser E . [Scintigraphy using 111In-labeled antimyosin in Churg-Strauss vasculitis with myocardial involvement]. Nuklearmedizin. 1990; 29(4):177-9. View

Hnatowich D, Fritz B, Virzi F, Mardirossian G, Rusckowski M . Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody. Nucl Med Biol. 1993; 20(2):189-95. DOI: 10.1016/0969-8051(93)90114-a. View

10.

Virgolini I, Muller C, Fitscha P, Chiba P, Sinzinger H . Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosis. Prog Clin Biol Res. 1990; 355:271-80. View

11.

Frist W, Yasuda T, SEGALL G, Khaw B, Strauss H, Gold H . Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation. 1987; 76(5 Pt 2):V81-5. View

12.

Khaw B, Strauss H, Cahill S, Soule H, EDGINGTON T, Cooney J . Sequential imaging of indium-111-labeled monoclonal antibody in human mammary tumors hosted in nude mice. J Nucl Med. 1984; 25(5):592-603. View

13.

Levine S, Levine M, Sharp K, Brooks D . Theory of the electrokinetic behavior of human erythrocytes. Biophys J. 1983; 42(2):127-35. PMC: 1329215. DOI: 10.1016/S0006-3495(83)84378-1. View

14.

SPAR I, VARON M, GOODLAND R, Schwartz S . Isotopic detection of thrombi. Arch Surg. 1966; 92(5):752-8. DOI: 10.1001/archsurg.1966.01320230100019. View

15.

Huston J, Levinson D, Tai M, Novotny J, Margolies M, Ridge R . Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A. 1988; 85(16):5879-83. PMC: 281868. DOI: 10.1073/pnas.85.16.5879. View

16.

Van Vlies B, van Royen E, Visser C, Meyne N, Van Buul M, Peters R . Frequency of myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass grafting. Am J Cardiol. 1990; 66(17):1191-5. DOI: 10.1016/0002-9149(90)91097-p. View

17.

Khaw B, Gold H, Leinbach R, Fallon J, Strauss W, Pohost G . Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments. Circulation. 1978; 58(6):1137-42. DOI: 10.1161/01.cir.58.6.1137. View

18.

Khaw B, Strauss H, MOORE R, Fallon J, Yasuda T, Gold H . Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. J Nucl Med. 1987; 28(1):76-82. View

19.

Khaw B, Klibanov A, ODonnell S, Saito T, Nossiff N, Slinkin M . Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med. 1991; 32(9):1742-51. View

20.

Addonizio L, Michler R, Marboe C, Esser P, Johnson L, SELDIN D . Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. J Am Coll Cardiol. 1987; 9(3):555-64. DOI: 10.1016/s0735-1097(87)80048-7. View